Literature DB >> 2986878

Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu mice.

C Kishimoto, K Kuribayashi, T Masuda, N Tomioka, C Kawai.   

Abstract

To clarify the immune mechanism in myocarditis, we examined by immunofluorescence techniques the serial changes in percentages of T and B lymphocytes in the heart, spleen, and peripheral blood of DBA/2 mice inoculated with encephalomyocarditis (EMC) virus (experiment I). B cells were demonstrated by staining with fluorescein isothiocyanate (FITC)-labeled rabbit antimouse immunoglobulin (Ig). T cells were demonstrated with rat anti-Thy1.2 monoclonal antibody plus FITC-labeled antimouse Ig. There was a marked decrease in T cells in peripheral blood and a moderate decrease in the cells in the spleen on day 14. There were no significant changes in B cells in peripheral blood or spleen throughout the entire period and T cells accounted for approximately 80% of the cells in the myocardium on days 7 and 14. To confirm the involvement of T cells in the development of myocarditis, we also carried out studies in which BALB/c-nu/nu mice (group 1, n = 58), BALB/c-nu/+ mice (group 2, n = 54), and BALB/c-nu/nu mice injected with 5 X 10(7) spleen cells from BALB/c-nu/+ mice (group 3, n = 50) were inoculated with EMC virus (experiment II). Four mice from each of the three groups were killed on day 6 for virologic studies. In experiment II, there were no significant differences in the incidence of myocarditis among the three groups. Virus titrations of the heart and serum neutralizing antibody titers did not show any significant differences between the three groups on days 6 and 16.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 2986878     DOI: 10.1161/01.cir.71.6.1247

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

1.  Enhanced production of macrophage inflammatory protein 2 (MIP-2) by in vitro and in vivo infections with encephalomyocarditis virus and modulation of myocarditis with an antibody against MIP-2.

Authors:  C Kishimoto; H Kawamata; S Sakai; H Shinohara; H Ochiai
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Effects of levamisole, an immunomodulator, upon murine encephalomyocarditis virus myocarditis.

Authors:  C Kishimoto; H Takada; Y Hiraoka; M Kurokawa; H Ochiai
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

3.  Antiinflammatory autoimmune cellular responses to cardiac troponin I in idiopathic dilated cardiomyopathy.

Authors:  Carmel M Halley; Jason M Lappé; Anne C Cotleur; Kevin Shrestha; Allen G Borowski; Clara Pelfrey; Richard Ransohoff; W H Wilson Tang
Journal:  J Card Fail       Date:  2011-02-26       Impact factor: 5.712

Review 4.  Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management.

Authors:  M T Kearney; J M Cotton; P J Richardson; A M Shah
Journal:  Postgrad Med J       Date:  2001-01       Impact factor: 2.401

5.  Muronomab-CD3 for pediatric acute myocarditis.

Authors:  Gregory Perens; Daniel S Levi; Juan Carlos Alejos; Glenn T Wetzel
Journal:  Pediatr Cardiol       Date:  2006-12-07       Impact factor: 1.655

6.  Immunomodulation by atorvastatin upregulates expression of gap junction proteins in coxsackievirus B3 (CVB3)-induced myocarditis.

Authors:  Alian Zhang; Huili Zhang; Shiyao Wu
Journal:  Inflamm Res       Date:  2009-09-23       Impact factor: 4.575

7.  Verapamil ameliorates the clinical and pathological course of murine myocarditis.

Authors:  R Dong; P Liu; L Wee; J Butany; M J Sole
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

8.  The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis.

Authors:  H Takada; C Kishimoto; Y Kuroki; I Matsushita; Y Hiraoka; M Kurokawa; H Ochiai; S Sasayama
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

Review 9.  Dilated cardiomyopathy update: infectious-immune theory revisited.

Authors:  Chuichi Kawai; Akira Matsumori
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

10.  QRS voltages are transiently increased at the superacute stage of experimental myocarditis.

Authors:  Chiharu Kishimoto; Minoru Ohmae; Nobuyoshi Tomioka
Journal:  Exp Clin Cardiol       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.